InvestorsHub Logo
Followers 59
Posts 9079
Boards Moderated 0
Alias Born 08/20/2000

Re: None

Saturday, 01/25/2003 12:31:32 PM

Saturday, January 25, 2003 12:31:32 PM

Post# of 15
Integrated Surgical Systems, Inc. Reaches An Agreement With Dr. Kenneth Krackow And Buffalo General Hospital/Kaleida Health To Be The Third Site For US FDA Mandated Clinical Trials For The ROBODOC Surgical Assistant System (The ROBODOC)

DAVIS, CA, Dec. 03, 2002 (INTERNET WIRE via COMTEX) -- Integrated Surgical Systems, Inc. (ISS) (OTCBB: RDOC), a pioneer in medical robotics and a leader in image-directed, semi-autonomous robotic products for surgical applications, announces that it has reached an agreement with Buffalo General Hospital/Kaleida Health and Dr. Kenneth Krackow for their participation as the third clinical site in the US FDA mandated Total Hip Arthroplasty (THA) procedure for the ROBODOC System.

Commenting on this agreement, Ramesh Trivedi, President and CEO of ISS, stated, "This is a very important step in our plan to complete the clinical trials as thoroughly and as rapidly as possible. To date, a total of 89 patients have either already undergone the surgeries or are waiting to be operated as a part of the current clinical studies. With other clinical sites on the West Coast, in the Southwest, we were looking for a highly reputable site on the East Coast."

"Dr. Krackow's familiarity with the ROBODOC system goes back several years. He played a key role in helping ISS develop the Total Knee Arthroplasty procedure for the ROBODOC system, which has been commercially available outside of the USA since 2000. His reputation as the premier orthopedic surgeon throughout the world, combined with his keen interest in the robotics technology, made him the ideal choice. We are very honored that Dr. Krackow has agreed to participate in this study."

"Ever since I collaborated with ISS in advising and guiding them through the development of ROBODOC TKA procedure, I have been very intrigued and impressed with the robotics technology and its potential in the orthopedic surgeries. Participation in the clinical trials seemed like an excellent way to further involve myself, my staff and the institution with this technology," commented Dr. Krackow.

Integrated Surgical Systems designs, manufactures, sells and services image-directed, computer-controlled robotic products for use in orthopedic and neurosurgical procedures. Our ROBODOC(R) Surgical Assistant System is the world's leading robotic system for hip and knee replacement surgery. NeuroMate, our neurosurgery system, is the first robotic technology-based system for use in stereotactic brain surgery.

Except for the historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties, including the timely development and market acceptance of new products and upgrades to existing products, the impact of competitive products and pricing, and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission (SEC).

ROBODOC(R) is a registered trademark of Integrated Surgical Systems, Inc.

NeuroMate(TM) is a trademark of Integrated Surgical Systems, S.A.

http://www.robodoc.com

CONTACT:
Ramesh C. Trivedi, Ph.D.
President and CEO
Integrated Surgical Systems
530-792-2600
Charles Novak
CFO
Integrated Surgical Systems
530-792-2600

.

.......According to the Great Pumpkin, ".....You're in .....iHub....., Charlie Brown....."!!!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.